The method of electrohydrodynamic atomization (EHDA), used in applications such as fuel combustion, has recently started making an appearance in the pharmaceutical world. It has been published that EHDA can aerosolize DNA without loss of structural integrity. EHDA does not apply the shear forces felt by other devices such as the jet nebulizer and ultrasonic nebulizer. It was proposed that EHDA would also be a better technique for atomizing proteins. Of the published papers on the topic, the outcomes of protein activity after being processed through EHDA have been mixed. Some proteins keep 100% activity after spraying while other lose activity depending on flow rates or concentration. Our research focused on comparing two enzymes (chymotrypsin and citrate synthase) atomized through jet nebulization and EHDA. Structural integrity was monitored using enzymatic assays. It appeared that the enzymes remained more active after being processed through the EHDA system compared with the jet nebulizer. In addition, properties that helped retain enzymatic activity after processing were an increase in enzymes concentration, an increase in flow velocity, and a high melting temperature.
Introduction
Many therapeutic proteins are difficult molecules to work with in that their properties and functions are unique to each protein. Unlike DNA, their three dimensional shape is essential for their function. Moreover, this three dimensional shape (secondary and tertiary structure) is determined by the bends and folds in the amino acid sequence generated by the electrostatic interactions, hydrogen bonds and hydrophobichydrophilic interactions between neighboring amino acids. These bonding interactions are weak thus making proteins susceptible to chemical (e.g. oxidation and deamidation) and physical (e.g. aggregation and precipitation) degradation. Methods for manufacturing proteins and delivering them to the body can often denature a protein before it reaches the target site within the body.
The vast majority of protein-base pharmaceuticals are given through injections (intravenous, intramuscular, subcutaneous and intraperitoneal). Although, a more contemporary method that is gaining popularity involves the inhalation of medicinal aerosols. Inhaled therapeutics provide a noninvasive delivery route that avoids the first-pass metabolism, which is especially important for protein delivery. In addition, the lungs have a large surface area (about 75 m 2 ) with a thin alveolar epithelium that allows rapid absorption of larger molecules into the blood stream. FDA approved delivery devices include jet nebulizers, ultrasonic nebulizers, metered-dose inhalers (MDIs), and dry powder inhalers (DPIs). The problem with most of these devices is that only a fraction (usually less than 25%) of the drug actually reaches its target location [1, 2] . In addition, aerosols formed from these inhalers are generally not monodisperse in size distribution thus providing at best, heterogeneous deposit in lungs and, at worst, significant mouth and throat deposition and exhalation issues. The optimal aerosol diameter for a pulmonary delivery is between 1-5 microns [3] . A new method exhibiting enhanced aerosolization potential for proteins and other macromolecular therapeutics is electrohydrodynamic atomization (EHDA). This method is capable of formulating monodisperse drops and has the expectation of using 80% less drug to achieve the same efficacy as DPIs [4] .
There are only a handful of published journal papers where researchers evaluate spraying proteins alone. Of these handful, a few of the papers focus only on the size of the resulting protein drop neglecting to examine if the proteins remain active [5] [6] [7] . Three papers did analyze protein activity, although all three papers looked at different proteins. Gomez et al. [8] examined insulin finding no change in activity from sprayed versus non-sprayed samples. Pareta et al. [9] investigated the impact of EHD spraying on bovine serum albumin (BSA). Secondary structure was monitored using circular dichroism and a slight, insignificant change in structure was observed. This paper noted that higher protein concentrations correlated to less structural degradation of the BSA protein after spraying. However, Gowadia and Dunn-Rankin [10] used an assay to monitor the activity of a lipase after spraying and found that enzyme activity dropped from 90% of the non-sprayed activity to 43% when decreasing the flow rate from 29 cc/hr to 9 cc/hr. It has been shown from Ganan-Calvo [11] that decreasing the flow rate decreases the drop size. This indicates that a dramatic drop in flow rate creates a significant decrease in drop size, which has been observed to decrease protein activity. This loss in activity correlates to an observation of Maa et al. [12, 13] who associated protein stability with surface area to volume ratios. They noted a linear relationship between droplet diameter and protein aggregation. However, all the papers that monitor protein activity or structural changes failed to observe or measure drop size. Thus comparing EHDA technology to current aerosol systems is not possible. Maa's previous efforts clearly show a surface to volume dependence that must be equated for a useful comparison to be obtained.
Other biological molecules have been sprayed successfully using EHDA. The earliest example, in 1995, cholesterol was sprayed [14] . More recently, a series of papers [15] [16] [17] have shown that DNA (sizes from 4.6 kb to 15.3 kb) does not degrade when sprayed. The authors hypothesized the efficacy improvement observed in EHDA over other aerosolization devices was due to the decrease in shear forces and lower residence times.
The purpose of this investigation is to understand the parameters affecting protein stability during EHDA and jet nebulization. Two different enzymes were used, one that is considered stable (chymotrypsin) and the other moderately unstable (citrate synthase). Both enzymes were assayed to determine activity before and after spraying and nebulization.
Materials and Methods
All the chemical and biological materials were purchased from Sigma-Aldrich (St. Louis, MO).
EHDA
The solutions were all prepared the day of the experiment and all experiments were carried out at room temperature. For the EHDA experiments, the 7 ml of protein solution was loaded into the stainless steel syringe. The solution was pumped at a rate of 0.008 ml/min through the nozzle, with a 4 mm separation between the nozzle and the grounded ring. Large voltages (ranging from 3 to 6 kilovolts) were applied to the nozzle in order to create a stable jet profile called the Taylor cone [18] . The drops were collected in an aluminum dish. Both positive and negative voltages were used to observe if the polarity had any affect.
In addition, to determine if forces other than the electric potential were affecting the enzyme during the EHDA runs, a few experiments were conducted in the EHDA apparatus without applying any current using the same volumetric flow rate as above.
Jet Nebulizer
For the jet nebulizer, 6 ml of the enzyme solution was placed into the nebulizer's reservoir. The nebulizer experiment began when the inlet air hose was turned on to a pressure of 1.1 Bar. Samples were drawn out of the nebulizer at 0 minutes (before air flow), 2 minutes, 5 minutes, 10 minutes and 15 minutes. Samples could not be immediately analyzed so they were placed on ice until the assay and UV spectrophotometric analysis could be done.
Protein Assays
The assay used to detect activity for chymotrypsin involves a reaction with N-Benzoyl-L-Tyrosine ethyl ester (BTEE). Chymotrypsin cleaves BTEE in the presence of water to create N-Benzoyl-L-Tyrosince and ethanol. The reaction is monitored by the UV absorption of the cleaved N-Benzoyl-L-Tyrosine at 256 nm.
The assay is a coupled reaction for citrate synthase. The first reaction is the first step in the citric acid cycle. It uses actyl-CoA and oxaloacetate to create citrate. The second reaction uses the citrate to cleave 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) that results in a mercaptide ion that absorbs UV light at 412 nm.
The last assay performed was a thin film assay. This encompassed leaving a droplet of enzyme solution sitting on the countertop at room temperature for a period of time. This was done to determine how much degradation is caused by thermal affects.
UV Spectrophotometry
To determine if the proteins were active, they were monitored using an assay whose products could be measured by UV spectrophotometry. Protein samples were immediately taken after processing and analyzed with the appropriate assay for loss of activity. The 1 ml of the assay mixture was placed in a quartz cuvette and observed for 3 minutes, recording the whole wavelength spectrum (from 250 nm to 800 nm) every 10 seconds for the first minute and every 20 sec for the last two minutes. Non-sprayed protein samples were assayed before and after the EHDA and nebulizer experiments as positive controls.
Results

Rate of Absorbance
The absorbance at the corresponding wavelength was measured with the UV spectrophotometer for the particular assay. These absorbencies were obtained over a 3 minute interval and then plotted with time vs. absorbance. The rate of absorbance over time was determined by fitting a line to the data points of the plot. Enzyme activity was compared between methods by calculating a percent activity. Percent activity was found by dividing the sample's rate of absorbance by the positive control's rate of absorbance (1).
The lower the value of percent activity the more the enzymes degraded during atomization processing.
Chymotrypsin
The chymotrypsin experiments were originally run without the methanol in the chymotrypsin solution. The results (not shown) had no degradation occurring in the nebulizer or the EHDA. It was decided that the addition of methanol would make the chymotrypsin a bit unstable and would also help configure the EHDA nozzle to a more uniform Taylor cone.
For chymotrypsin, the UV spectrophotometer analysis of the assay gave peak absorbances at wavelength of 256 nm. From the results below (Table 3-1) , it can be seen that the chymotrypsin remained active during both the EHDA and nebulizer experiments. The percent activity for chymotrypsin was calculated for the EHDA and each nebulizer time point. The percent activity for the EHDA was found to be 106%. The percent activity for each of the nebulizer time points was not significantly different, nor did the percent activity correlate in any way with the resonance time in the nebulizer. The percent activity for all the time points were averaged together to get an average nebulizer percent activity of 93%. Therefore it is easy to conclude that the chymotrypsin did not statistically degrade during either the nebulizer or the EHDA. 
Citrate Synthase
Citrate synthase is a very fragile molecule and is evident by a decrease in activity to 64% simply loading the aerosol devices. Both the nebulizer and the EHDA degraded the enzyme (Figure 1 ), but residence time dependence was exhibited with the jet nebulizer. After 2 minutes of nebulization, activity decreases from 64% to 26 %. Activity becomes negligible after 10 minutes (e.g. 6 %) thus further losses cannot be monitored with accuracy.
The EHDA activity was slightly higher. For the positive 5.2 kV trials, the activity was 21% and for the negative 5.2kV trials the activity was 22%. The EHDA sample without applied voltage had an activity of 26%. This demonstrates that the degradation is not a function of droplet size in this device (without applied voltage the droplet diameter is about 2 millimeters, with voltage the diameter drops to 37 microns), but suggests that degradation is a systematic problem either from the tubing or collection system. It also clearly demonstrates that the droplet surface charge does not impact protein stability either enhancing or interfering with protein distribution or weak electrostatic interactions.
The systemic losses experienced in both the nebulizer and EHDA system were troubling and could not be isolated even with refined sterilization procedures. This could be due to the low concentrations used that made the molecule inherently unstable. However, experiments to investigate degradation as a result of the collection process for the EHDA were undertaken. Observing activity loss of a 0.1 ml droplet on an aluminum pan over 5 to 15 minutes demonstrated that the exposure time of the protein film has no observable trend (Table 2) . Instead it correlates to the same 64% loading loss observed previously (i.e., average of all time points was 56%). Table 2 . Results from thin film assay, sitting on the countertop for 5 -15 minutes results in about 50% loss of enzymatic activity.
% Activity
Sitting for 5 min 50%
Sitting for 10 min 64%
Sitting for 15 min 53%
It appears that aerosolization of the citrate synthase protein in a single pass results in a 74% loss in protein activity regardless of the method of aerosolization. It is the simple fact that the EHDA system only requires one pass that provides an enhance performance over the nebulization system. This finding is consistent with the findings on other macromolecular therapeutics.
Proteins
It was interesting to see that a protein considered to be very stable works well for atomization while an unstable protein does not. In addition, the three other proteins examined with EHDA had varying results too. A table of protein properties and experimental parameters was constructed from the proteins EHD sprayed in order to find some correlating value ( Table  3 ). The protein properties examined were the size of the protein, its isoelectric point (the pH at which the protein is neutral), the type or function of the protein, the melting temperature of the protein, and the percent of hydrophobic amino acids in the protein sequence (determined by an equation from [19] ). From the experimental setup, the parameters looked at were the pH of the solution used in the study, the concentration of the protein in solution, and the overall protein activity at the end of the experiment.
It can be seen from Table 3 that there does not seem to be an obvious correlating parameter by which a protein succeeds or fails in the EHDA. However, there is a slight trend to be seen with melting temperature. It appears that as the melting temperature of a protein increases, the results in the EHDA gradually improve. The melting point of a protein is defined as the temperature at which the protein is 50% denatured, although this value can change depending on the composition of the solution. Proteins with melting temperature above 70 o C are safe while proteins below that temperature don't always fair as well.
Conclusion
It has been shown that the EHDA is a viable technique to create an aerosol of a stable protein, chymotrypsin. Chymotrypsin showed no degradation in the EHDA and very little in the nebulizer. However, this is not the case with the sensitive protein, citrate synthase. Both methods significantly denatured this enzyme. Although the EHDA does sustain more activity regardless of operation time because it operates in a single pass fashion. These two experiments alone indicate that the EHDA can process proteins with a higher percent activity than the nebulizer.
Melting Temperature
It is already known that concentration and flow velocity can affect the stability of an enzyme processed through EHDA. However, there appears to be a slight correlation between the protein stability in the EHDA and the proteins melting temperature. The emerging trend shows that proteins with a higher melting temperature have greater activity after EHD spraying. More work needs to be done with proteins of varying melting points in order to give credit to this theory. Table 3: A table of properties of proteins in this experiment and the other three papers that reported protein activity. Size of the protein is in kDa, "PI" is the isoelectric point, "Type" is the type or function of the protein, "pH" is the pH of the solution used in the study, Tm is the melting temperature of the protein, "Conc." is the concentration of protein used in each study, "% hydro" is the percentage of the amino acid sequence that is considered hydrophobic (equation from [19] ), and "Results" show the % activity protein after EHD spraying (except for BSA that monitored activity based on structure, these results could only be quantified in words). 
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